Functional characterization of 21 CYP3A4 variants on amiodarone metabolism in vitro

被引:15
|
作者
Yang, Cheng-Cheng [1 ]
Zheng, Xiang [1 ]
Liu, Teng-Hui [1 ]
Wang, Chen-Chen [1 ]
Tang, Peng-Fei [1 ]
Chen, Zhe [1 ]
Zhang, Bo-Wen [1 ]
Fang, Ping [1 ]
Hu, Guo-Xin [1 ]
Cai, Jian-Ping [2 ,3 ]
机构
[1] Wenzhou Med Univ, Sch Pharm, Wenzhou 325035, Zhejiang, Peoples R China
[2] Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China
[3] Minist Hlth, Beijing Inst Geriatr, Beijing, Peoples R China
关键词
Allelic variant; amiodarone; CYP3A4; polymorphisms; desethylamiodarone; drug metabolism; GENETIC POLYMORPHISMS; N-DEETHYLATION; IDENTIFICATION; PHARMACOKINETICS; VARIABILITY;
D O I
10.1080/00498254.2017.1414971
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1.Cytochrome P450 3A4 (CYP3A4) is an important member of the cytochrome P450 enzyme superfamily, with 33 allelic variants reported previously. Genetic polymorphisms of CYP3A4 can produce a significant effect on the efficacy and safety of some drugs, so the purpose of this study was to clarify the catalytic characteristics of 22 CYP3A4 allelic isoforms, including 6 novel variants in Han Chinese population, on the oxidative metabolism of amiodarone in vitro. 2.Wild-type CYP3A4*1 and other variants expressed by insect cells system were incubated respectively with 10-500 mu M substrate for 40 min at 37 degrees C and terminated at -80 degrees C immediately. Then these samples were treated as required and detected with ultra-performance liquid chromatography-tandem mass spectrometry used to analyze its major metabolite desethylamiodarone. 3.Among the 21 CYP3A4 variants, compared with the wild-type, the intrinsic clearance values (V-max/K-m) of two variants were apparently decreased (11.07 and 2.67% relative clearance) while twelve variants revealed markedly increased values (155.20 similar to 435.96%), and the remaining of seven variants exhibited no significant changes in enzyme activity. 4.This is the first time report describing all these infrequent alleles for amiodarone metabolism, which can provide fundamental data for further clinical studies on CYP3A4 alleles.
引用
收藏
页码:120 / 126
页数:7
相关论文
共 50 条
  • [31] Metabolism of Quetiapine by CYP3A4 and CYP3A5 in Presence or Absence of Cytochrome B5
    Bakken, Gry Vibeke
    Rudberg, Ida
    Christensen, Hege
    Molden, Espen
    Refsum, Helge
    Hermann, Monica
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (02) : 254 - 258
  • [32] Functional polymorphisms in the CYP3A4, CYP3A5, and CYP21A2 genes in the risk for hypertension in pregnancy
    Coto, Eliecer
    Tavira, Beatriz
    Marin, Rafael
    Ortega, Francisco
    Lopez-Larrea, Carlos
    Ruiz-Ortega, Marta
    Ortiz, Alberto
    Diaz, Marta
    Corao, Ana I.
    Alonso, Belen
    Alvarez, Victoria
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 397 (03) : 576 - 579
  • [33] Effect of NIPRISANA® on CYP3A4 activity in vitro
    Adzu, Bulus
    Masimirembwa, Collen
    Mustapha, Kudirat Bola
    Thelingwani, Roslyn
    Kirim, Rukaiyatu Abdullahi
    Gamaniel, Karniyus Shingu
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2015, 40 (01) : 115 - 118
  • [34] Impaired Drug Metabolism Caused by Compound Heterozygous Loss-of-Function Variants in CYP3A4: A Case Report
    Kang, Han Byul
    Cohn, Iris
    Mahant, Sanjay
    Costain, Gregory
    Ito, Shinya
    Verstegen, Ruud H. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025,
  • [35] Functional characterization of CYP2C19 variants in nebivolol 4-hydroxlation in vitro
    Zhou, Xiao-Yang
    Hu, Xiao-Xia
    Li, Meng-Fang
    Wang, Hao
    Zhang, Li-Qun
    Hu, Guo-Xin
    Cai, Jian-Ping
    DRUG TESTING AND ANALYSIS, 2018, 10 (05) : 807 - 813
  • [36] Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians
    Kohlrausch, Fabiana B.
    Carracedo, Angel
    Hutz, Mara H.
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (03) : 1453 - 1460
  • [37] The relative role of CYP3A4 and CYP3A5 in eplerenone metabolism
    McGraw, Joseph
    Cherney, Mitchell
    Bichler, Katherine
    Gerhardt, Armin
    Nauman, Mirielle
    TOXICOLOGY LETTERS, 2019, 315 : 9 - 13
  • [38] Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammation
    Molanaei, Hadi
    Stenvinkel, Peter
    Qureshi, Abdul Rashid
    Carrero, Juan Jesus
    Heimburger, Olof
    Lindholm, Bengt
    Diczfalusy, Ulf
    Odar-Cederlof, Ingegerd
    Bertilsson, Leif
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (05) : 571 - 577
  • [39] Cluster headache polygenetic risk and known functional variants of CYP3A4 are not associated with treatment response
    Petersen, Anja Sofie
    Barloese, Mads
    Lund, Nunu
    Pedersen, Adam Friis
    Soborg, Marie-Louise Kulas
    Chalmer, Mona Ameri
    Callesen, Ida
    Winsvold, Bendik Slagsvold
    Zwart, John-Anker
    DBDS Genomic Consortium, Sisse Rye
    Ostrowski, Sisse Rye
    Pedersen, Ole Birger
    Sellebjerg, Finn
    Sondergaard, Helle Bach
    Hansen, Malene Bredahl
    Jensen, Rigmor Hojland
    Hansen, Thomas Folkmann
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (05) : 1425 - 1434
  • [40] The roles of CYP2C19 and CYP3A4 in the in vitro metabolism of β-eudesmol in human liver: Reaction phenotyping and enzyme kinetics
    Muhamad, Nadda
    Na-Bangchang, Kesara
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2023, 11 (06):